Mirum Pharmaceuticals (MIRM) Exchange Rate Effect (2019 - 2026)
Mirum Pharmaceuticals' (MIRM) quarterly Exchange Rate Effect came in at -$1.3 million in Q1 2026, down 220.57% year-on-year from $1.1 million in Q1 2025, and down 211.76% quarter-over-quarter from -$408000.0 in Q4 2025.
Mirum Pharmaceuticals (MIRM) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Exchange Rate Effect history runs 8 years deep, the most recent figure standing at -$1.3 million for Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 220.57% year-over-year to -$1.3 million in Q1 2026; TTM through Mar 2026 was $895000.0, a 352.11% increase from a year earlier, with the FY2025 full-year figure at $3.2 million, up 348.42% from the prior year.
- Exchange Rate Effect eased to -$1.3 million in Q1 2026 per MIRM's latest filing, from -$408000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $2.2 million in Q2 2025 and bottomed at -$1.4 million in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$3000.0 (2022), against an average of $31294.1.
- Across the five-year window, Exchange Rate Effect sank 1733.33% in 2022 and surged 6366.67% in 2023, its largest moves.
- Year by year, Exchange Rate Effect stood at $85000.0 in 2022, then grew by 27.06% to $108000.0 in 2023, then plunged by 1376.85% to -$1.4 million in 2024, then surged by 70.41% to -$408000.0 in 2025, then plunged by 211.76% to -$1.3 million in 2026.
- Per Business Quant, the three latest MIRM Exchange Rate Effect figures stand at -$1.3 million (Q1 2026), -$408000.0 (Q4 2025), and $349000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mirum Pharmaceuticals | 6.73 Bn | 6.34 Bn | 131.08 Mn | -1.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.27 Mn |
| Mar 31, 2026 | -1.27 Mn |
| Dec 31, 2025 | -408,000.00 |
| Dec 31, 2025 | -408,000.00 |
| Sep 30, 2025 | 349,000.00 |
| Sep 30, 2025 | 349,000.00 |
| Jun 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | -1.38 Mn |
| Dec 31, 2024 | -1.38 Mn |
| Sep 30, 2024 | 88,000.00 |
| Sep 30, 2024 | 88,000.00 |
| Jun 30, 2024 | -119,000.00 |
| Jun 30, 2024 | -119,000.00 |
| Mar 31, 2024 | 113,000.00 |
| Mar 31, 2024 | 113,000.00 |
| Dec 31, 2023 | 108,000.00 |
| Dec 31, 2023 | 108,000.00 |